| Literature DB >> 28166270 |
Angelica Van Goor1, Chris M Ashwell2, Michael E Persia3, Max F Rothschild1, Carl J Schmidt4, Susan J Lamont1.
Abstract
Climate change and disease have large negative impacts on poultry production, but little is known about the interactions of responses to these stressors in chickens. Fayoumi (heat and disease resistant) and broiler (heat and disease susceptible) chicken lines were stimulated at 22 days of age, using a 2x2x2 factorial design including: breed (Fayoumi or broiler), inflammatory stimulus (lipopolysaccharide (LPS) or saline), and temperature (35°C or 25°C). Transcriptional changes in spleens were analyzed using RNA-sequencing on the Illumina HiSeq 2500. Thirty-two individual cDNA libraries were sequenced (four per treatment) and an average of 22 million reads were generated per library. Stimulation with LPS induced more differentially expressed genes (DEG, log2 fold change ≥ 2 and FDR ≤ 0.05) in the broiler (N = 283) than the Fayoumi (N = 85), whereas heat treatment resulted in fewer DEG in broiler (N = 22) compared to Fayoumi (N = 107). The double stimulus of LPS+heat induced the largest numbers of changes in gene expression, for which broiler had 567 DEG and Fayoumi had 1471 DEG of which 399 were shared between breeds. Further analysis of DEG revealed pathways impacted by these stressors such as Remodelling of Epithelial Adherens Junctions due to heat stress, Granulocyte Adhesion and Diapedesis due to LPS, and Hepatic Fibrosis/Hepatic Stellate Cell Activation due to LPS+heat. The genes and pathways identified provide deeper understanding of the response to the applied stressors and may serve as biomarkers for genetic selection for heat and disease tolerant chickens.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28166270 PMCID: PMC5293231 DOI: 10.1371/journal.pone.0171414
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Average number of RNA-sequencing reads generated for each chicken spleen within each treatment group (N = 4) before and after FASTQC filtering, and number of mapped reads, and percentage of sequencing depth analysis.
Intragenic regions are considered reads that mapped to all or part of an exon and therefore included as feature counts in HTSeq, whereas intergenic regions are reads that mapped outside of regions annotated as exons.
| Treatment group | Reads generated | Reads post-filtering | Mapped reads (%) | Transcriptome coverage (%) | Intragenic mapping (%) | Intergenic mapping (%) |
|---|---|---|---|---|---|---|
| F_TN_PBS | 24,200,942 | 19,841,278 | 17,480,166 (88.1%) | 12,987 (83.7%) | 89.3 | 10.7 |
| F_HS_PBS | 20,203,988 | 16,721,600 | 14,915,667 (89.2%) | 12,885 (83.1%) | 88.7 | 11.3 |
| F_TN_LPS | 28,607,883 | 23,464,251 | 21,023,969 (89.6%) | 12,534 (80.8%) | 89.2 | 10.8 |
| F_HS_LPS | 22,828,621 | 18,843,821 | 20,568,587 (90.1%) | 12,717 (82.0%) | 88.1 | 11.9 |
| B_TN_PBS | 17,551,738 | 14,404,416 | 12,863,143 (89.3%) | 12,692 (81.8%) | 89.6 | 10.4 |
| B_HS_PBS | 18,184,950 | 14,859,218 | 13,239,563 (89.1%) | 12,568 (81.0%) | 89.5 | 10.5 |
| B_TN_LPS | 19,724,297 | 16,050,493 | 14,236,787 (88.7%) | 12,675 (81.7%) | 88.3 | 11.7 |
| B_HS_LPS | 20,720,682 | 16,978,131 | 15,059,602 (88.7%) | 12,632 (81.5%) | 88.5 | 11.5 |
| Average | 21,502,888 | 17,645,401 | 16,173,436 (89.1%) | 12,711 (82.0%) | 88.9 | 11.1 |
Fig 1Phenotypic responses to treatment in the Fayoumi and broiler chicken breeds at 22 days of age after 7 hours of heat treatment at 35°C, and/or 3.5 hours post lipopolysaccharide (LPS) treatment.
Cloacal body temperature and blood chemistry components measured using an iSTAT machine. Chicken breeds are depicted by different colors with broiler in red and Fayoumi in black. A. Body temperature response to treatments. B. Blood chemistry component changes in response to heat, C. LPS, and D. LPS+heat. * indicates significant pairwise difference between breeds (P ≤ 0.05).
Fig 2A heat map showing the number of differentially expressed genes (DEG) and the direction of log fold change (LFC) of expression values in the spleen of the Fayoumi and broiler chicken breeds at 22 days of age after 7 hours of heat treatment at 35°C, and/or 3.5 hours post lipopolysaccharide (LPS) treatment.
DEG have an FDR ≤ 0.05 and LFC ≥ ± 2.
Fig 3Venn diagrams depicting shared differentially expressed genes between treatments and chicken breeds.
Fayoumi and broiler chicken breeds at 22 days of age after 7 hours of heat treatment at 35°C, and/or 3.5 hours post lipopolysaccharide (LPS) treatment. Green is treatment with LPS, red is heat, and blue is LPS+heat. Genes were considered differentially expressed with LFC ≥ ± 2 and FDR ≤ 0.05.
Fig 4Gene ontology (GO) enrichment analyses showing top significantly associated GO terms based on differentially expressed genes.
Fayoumi and broiler chicken breeds at 22 days of age after 7 hours of heat treatment at 35°C, and/or 3.5 hours post lipopolysaccharide (LPS) treatment. All enrichments had a p value ≤ 0.05.
Fig 5Validation of RNA-sequencing with Fluidigm technology.
A total of 32 RNA samples (4 per treatment) were assayed in triplicate on a FlexSix IFC where we tested mRNA expression of 14 (IL-10, IL-6, IL-1beta, iNOS, IFN-gamma, CCL4, ANGPL4, CD40, IL-18, HSPA2, TLR4, S100A1, MAPK9, and HSF4) test genes and 2 housekeeping genes. Log2 fold change determined using EdgeR with RNA-sequencing (blue bars) and Fluidigm technology (orange bars). The correlation between the two technologies was (R = 0.86).
Ingenuity pathway analysis results for differentially expressed genes due to treatment within breed.
The numbers included in the table are P values. The top 5 significant (P ≤ 0.05) canonical pathways, upstream regulators, and diseases and disorders are listed for each contrast.
| Canonical pathways | Acute Phase Response Signaling | 2.02E-07 | Lipid Antigen Presentation by CD1 | 2.12E-02 |
| Extrinsic Prothrombin Activation Pathways | 2.60E-05 | Remodeling of Epithelial Adherens Junctions | 5.46E-02 | |
| Intrinsic Prothrombin Activation Pathway | 1.64E-04 | Macropinocytosis Signaling | 5.46E-02 | |
| Retinoate Biosynthesis I | 2.42E-04 | Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes | 7.40E-02 | |
| Coagulation System | 2.89E-04 | Paxillin Signaling | 8.01E-02 | |
| Upstream Regulators | TNF | 2.81E-13 | CYTH2 | 7.37E-04 |
| Lipopolysaccharide | 2.37E-12 | IPCEF1 | 7.37E-04 | |
| IKBKB | 3.09E-12 | SUV39H2 | 1.47E-03 | |
| IL1B | 5.63E-12 | LMCD1 | 1.47E-03 | |
| GH1 | 1.31E-10 | CYTH3 | 1.47E-03 | |
| Diseases and Disorders | Cardiovascular Disease | 3.68E-03 | Connective Tissue Disorders | 8.24E-04 |
| Developmental Disorder | 3.68E-03 | Inflammatory Response | 8.24E-04 | |
| Hematological Disease | 3.68E-03 | Skeletal and Muscular Disorders | 8.24E-04 | |
| Hereditary Disorder | 3.68E-03 | Infectious Diseases | 4.12E-02 | |
| Immunological Disease | 3.68E-03 | Cancer | 1.39E-02 | |
| Canonical Pathways | Atherosclerosis Signaling | 2.58E-06 | Altered T Cell and B Cell Signaling in Rheumatoid Arthritis | 1.30E-08 |
| LXR/RXR Activation | 3.99E-05 | Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 3.94E-08 | |
| Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 3.99E-05 | IL-10 Signaling | 2.08E-06 | |
| Glucocorticoid Receptor Signaling | 2.27E-04 | Atherosclerosis Signaling | 3.68E-06 | |
| Granulocyte Adhesion and Diapedesis | 2.39E-04 | IL-17A Signaling in Fibroblasts | 4.33E-06 | |
| Upstream Regulators | TNF | 4.39E-22 | TNF | 3.22E-51 |
| Lipopolysaccharide | 1.48E-15 | Lipopolysaccharide | 2.60E-45 | |
| TLR3 | 1.70E-13 | IL1B | 2.04E-36 | |
| IL1B | 1.55E-12 | NFkB (complex) | 3.68E-31 | |
| Prostaglandin E2 | 1.56E-12 | IFNG | 1.25E-24 | |
| Diseases and Disorders | Organismal Injury and Abnormalities | 3.15E-03 | Inflammatory Response | 2.88E-06 |
| Inflammatory Response | 3.15E-03 | Organismal Injury and Abnormalities | 2.74E-06 | |
| Cancer | 2.91E-03 | Cancer | 2.62E-06 | |
| Gastrointestinal Disease | 3.15E-03 | Inflammatory Disease | 2.09E-06 | |
| Metabolic Disease | 3.15E-03 | Infectious Diseases | 1.72E-06 | |
| Canonical Pathways | Hepatic Fibrosis/Hepatic Stellate Cell Activation | 2.58E-10 | Hepatic Fibrosis/Hepatic Stellate Cell Activation | 5.77E-09 |
| Axonal Guidance Signaling | 1.96E-09 | Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 2.71E-08 | |
| Aryl Hydrocarbon Receptor Signaling | 7.49E-06 | Granulocyte Adhesion and Diapedesis | 2.29E-07 | |
| Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 8.83E-06 | LPS/IL-1 Mediated Inhibition of RXR Function | 2.57E-07 | |
| Glutamate Receptor Signaling | 9.87E-06 | P38 MAPK Signaling | 3.78E-07 | |
| Upstream Regulators | TNF | 2.89E-46 | TNF | 5.41E-51 |
| TGFB1 | 6.78E-41 | Lipopolysaccharide | 1.97E-42 | |
| TP53 | 1.71E-40 | IL1B | 8.35E-35 | |
| Lipopolysaccharide | 7.86E-34 | TGFB1 | 2.12E-34 | |
| Vegf | 4.07E-28 | TP53 | 1.42E-27 | |
| Diseases and Disorders | Cancer | 1.38E-09 | Inflammatory Response | 3.82E-07 |
| Organismal Injury and Abnormalities | 1.38E-09 | Cancer | 4.76E-07 | |
| Gastrointestinal Disease | 1.12E-09 | Organismal Injury and Abnormalities | 4.76E-07 | |
| Hepatic System Disease | 4.20E-12 | Tumor Morphology | 7.94E-09 | |
| Reproductive System Disease | 2.74E-11 | Connective Tissue Disorder | 4.74E-07 | |